SCHEMBL8010133

SCHEMBL8010133

O=C(Cc1ccccc1)[N]C(=O)c1ccc2ccccc2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H4 Q96RI1 2/20 0.49
PLAU P00749 1/20 0.49
CES2 O00748 1/20 0.49
CES1 P23141 1/20 0.49
GRIN1 Q05586 1/20 0.48
GRIN2B Q13224 1/20 0.48
ACHE P22303 1/20 0.47
GPR52 Q9Y2T5 1/20 0.47
PTPN1 P18031 1/20 0.46
KDM4E B2RXH2 3/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
LMNA P02545 1/20 0.46
GAA P10253 1/20 0.46
HTT P42858 1/20 0.46
NPC1 O15118 1/20 0.45
CYP1A2 P05177 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
MEN1 O00255 3/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8009814 0.81 CES1 (0.50) CES2CES1LMNAMEN1KMT2A
SCHEMBL8009171 0.80 CES2 (0.59) PLAUCES2CES1PTPN1KDM4E
SCHEMBL1515809 0.78 PLAU (0.73) NR1H4PLAUCES2CES1ACHE
SCHEMBL8015971 0.78 SMN1; SMN2 (0.51) CES2CES1PTPN1KDM4ESMN1; SMN2
SCHEMBL699924 0.75 CES1 (0.61) CES2CES1LMNAGAAHTT
SCHEMBL14394377 0.72 CES2 (0.63) PLAUCES2CES1PTPN1KDM4E
SCHEMBL8010136 0.72 NR1H4 (0.59) NR1H4PLAUKDM4ESMN1; SMN2LMNA
SCHEMBL27900790 0.72 KMT2A (0.50) NR1H4PLAUCES2CES1GRIN1
SCHEMBL4308698 0.72 HDAC8 (0.53) NR1H4PLAUCES2CES1GRIN1
SCHEMBL8009663 0.71 CES2 (0.57) NR1H4PLAUCES2CES1PTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6117893-A Heterocyclic compounds having anti-diabetic activity and their use SANKYO COMPANY, LIMITED (JP) 2000-09-12 US disclosed
US-5977365-A HYPOGLYCEMIC AGENTS SANKYO COMPANY, LIMITED (JP) 1999-11-02 US disclosed
US-5962470-A Heterocyclic compounds having anti-diabetic activity and their use SANKYO COMPANY, LIMITED (JP) 1999-10-05 US disclosed
US-5886014-A TREATMENT AND/OR PROPHYLAXIS OF A VARIETY OF DISORDERS, INCLUDING HYPERLIPEMIA, HYPERGLYCEMIA, OBESITY, IMPAIRED GLUCOSE TOLERANCE (IGT), INSULIN RESISTANCE AND DIABETIC COMPLICATIONS SANKYO COMPANY, LIMITED (JP) 1999-03-23 US disclosed
US-5834501-A TREATING DIABETES OR HYPERLIPEMIA SANKYO COMPANY, LIMITED (JP) 1998-11-10 US disclosed
US-5739345-A HYPOGLYCEMIC AND ANTIDIABETIC AGENTS SANKYO COMPANY, LIMITED (JP) 1998-04-14 US disclosed
US-5624935-A ANTIDIABETIC AGENTS, HYPOGLYCEMIC AGENTS OR ANTILIPEMIC AGENTS SANKYO COMPANY, LIMITED 1997-04-29 US disclosed
EP-0676398-A2 Heterocyclic compounds having anti-diabetic activity, their preparation and their use SANKYO COMPANY LIMITED (JP) 1995-10-11 EP disclosed